According to Robert Kushner, an obesity researcher at Northwestern University Feinberg School of Medicine , who led one of the STEP studies, semaglutide is a "game-changer" for people with obesity
Li N, Wang B, Wang Y, Tian X, Lin J, Sun X, Sun Y, Zhang X, et al
This can be one of the most obvious and visible signs of GLP-1 weight loss for many women. 3
While inflammatory M1 macrophages contribute to tissue injury and fibrosis, M2 macrophages exhibit anti-inflammatory properties and promote tissue repair and regeneration
Furthermore, for patients already diagnosed with early or intermediate nonexudative AMD, GLP-1 therapy led to a notable 29% relative risk reduction in progression to advanced nonexudative AMD and a 27% reduction in the progression to exudative AMD